Table 2.
Short-Term Efficacy and the Efficacy Comparison of Different Types.
| Types | n | Short-term efficacy | Significant efficacy rate (%) | Efficacy rate (%) | Invalid rate (%) | CR + SR | MR + NR | χ2 value | P value | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CR | SR | MR | NR | (CR + SR)/n | (CR + SR + MR)/n | NR/n | ||||||
| Histologic type | ||||||||||||
| SCC | 29 | 6 | 10 | 6 | 7 | 55.2 | 75.9 | 24.1 | 16 | 13 | 0.146 | .702 |
| Others | 3 | 0 | 2 | 1 | 0 | 66.7 | 100 | 0 | 2 | 1 | ||
| Location | ||||||||||||
| Cervical | 6 | 1 | 3 | 1 | 1 | 66.7 | 83.3 | 16.7 | 4 | 2 | 0.375 | .945 |
| Thoracic (upper) | 9 | 2 | 3 | 2 | 2 | 55.6 | 77.8 | 22.2 | 5 | 4 | ||
| Thoracic (middle) | 11 | 3 | 3 | 3 | 2 | 54.5 | 81.8 | 18.2 | 6 | 5 | ||
| Thoracic (lower) | 6 | 0 | 3 | 1 | 2 | 50.0 | 66.7 | 33.3 | 3 | 3 | ||
| Length (cm) | ||||||||||||
| ≤4 | 10 | 4 | 4 | 1 | 1 | 80.0 | 90.0 | 10.0 | 8 | 2 | 6.112 | .047 |
| >4, ≤6 | 16 | 2 | 7 | 3 | 4 | 56.3 | 75.0 | 25.0 | 9 | 7 | 1.534 | .216 |
| >6 | 6 | 0 | 1 | 3 | 2 | 16.7 | 66.7 | 33.3 | 1 | 5 | 6.112 | .013 |
| TNM stage | ||||||||||||
| III | 12 | 4 | 4 | 2 | 2 | 66.7 | 83.3 | 16.7 | 8 | 4 | 0.847 | .358 |
| IV | 20 | 2 | 8 | 5 | 5 | 50.0 | 75.0 | 25.0 | 10 | 10 | ||
| KPS score | ||||||||||||
| ≥80 | 22 | 5 | 9 | 5 | 3 | 63.6 | 86.4 | 13.6 | 14 | 8 | 1.561 | .212 |
| <80 | 10 | 1 | 3 | 2 | 4 | 40.0 | 60.0 | 40.0 | 4 | 6 | ||
| PDT cycles | ||||||||||||
| 1 | 27 | 3 | 10 | 7 | 7 | 48.1 | 74.1 | 25.9 | 13 | 14 | 4.609 | .032 |
| 2-3 | 5 | 3 | 2 | 0 | 0 | 100 | 100 | 0 | 5 | 0 | ||
Abbreviations: CR, complete response; KPS, Karnofsky Performance Status; MR, minor response; NR, no response; PDT, photodynamic therapy; SCC, squamous cell carcinoma; SR, significant response.